Per the clinic, the patient developed cellulitis at the implant site and was treated with antibiotics (type not reported) on (b)(6) 2015.
On (b)(6) 2015, the patient experienced skin overgrowth at the implant site.
Subsequently, a biopsy punch was performed in order to expose the implant.
On (b)(6) 2016, the patient experienced an infection at the implant site, and was treated with oral antibiotics; however, the issue reoccurred, and the patient presented once more to clinic on (b)(6) 2016, with infection.
The patient was treated with another course of oral antibiotics.
|